GZMB and neoplasm: For example, in human, CD103+ TRM cells can produce granzyme B (GZMB) and IFN-γ, which can enhance recruitment of monocytes, NK cells, and XCR1+ cDC1 to the tumor site, resulting in anti-tumor (76, 77).